MiR-142-3p ameliorates high glucose-induced renal tubular epithelial cell injury by targeting BOD1

ConclusionMiR-142-3p ameliorates HG-induced renal tubular epithelial cell injury by targeting BOD1. The finding might provide novel insight into the role of miR-142-3p/BOD1 axis in DN treatment.
Source: Clinical and Experimental Nephrology - Category: Urology & Nephrology Source Type: research